DOI: 10.1097/mph.0000000000002841 ISSN: 1077-4114
Use of Maribavir for Multidrug Resistant Cytomegaloviremia in a Pediatric Oncology Patient
James E. Fisher, Kevin Mulieri, Elizabeth Finch, Jessica E. Ericson- Oncology
- Hematology
- Pediatrics, Perinatology and Child Health
Resistant and refractory cytomegalovirus (CMV) viremia can limit the provision of chemotherapy due to myelosuppression and end-organ dysfunction. Few therapies are available for children with clinically significant CMV viremia. We successfully used maribavir for a 4-year-old patient with lymphoma to complete his chemotherapy course. Resistance to maribavir did result after many months of therapy.